Pharmaceutical Sector

.

European Medicines Agency to review Samsung Bioepis’s Application of Humira biosimilar

European Medicines Agency to review Samsung Bioepis’s Application of Humira bios

On Monday, Samsung Bioepis, devoted to create affordable and high-quality biopharmaceutical and biosimilar products said is seeking regulatory approval in Europe to sell Humira, its copy of AbbVie Inc's rheumatoid arthritis drug.

Martin Shkreli Pleads not Guilty to New Charge brought Against Him

Martin Shkreli

A new charge was brought against Martin Shkreli, the Pharma industry entrepreneur accused of defrauding potential investors. On Monday, he pleaded not guilty to the updated indictment which brought a new conspiracy charge. He also jeered at the federal prosecutors.

Does Fewer Opioid Prescriptions in the U.S Reflect a Curb in the Wave of Addiction

Does Fewer Opioid Prescriptions in the U.S Reflect a Curb in the Wave of Addicti

On Friday, a data released by The New York Times revealed that in almost two decades for the very first time there has been a drop in the number of opioid prescriptions in the U.S.  

Pfizer planning to acquire Anacor Pharmaceuticals

Pfizer planning to acquire Anacor Pharmaceuticals

Pharmaceutical giant, Pfizer Inc has entered into adefinitive merger agreementwith Anacor Pharmaceuticals.

Pfizer to restrict use of its products in lethal injections

Pfizer to restrict use of its products in lethal injections

Second largest pharmaceutical company in the world, Pfizer has strengthened its control on the distribution channels in order to ensure that any of its products are not used in lethal injections.

Abbott Laboratories Acquiring Medical Technology and Service Company St. Jude for $25 Billion

Abbott Laboratories Acquiring Medical Technology and Service Company St. Jude fo

On Thursday, Abbott Laboratories said it would buy Minnesota based, medical technology company St. Jude Medical Inc for $25 billion. Te main aim is to enlarge its heart device business. However, investors are worried that this acquisition will most probably not pay off like it's promised. It will be a cash-and-stock acquisition. Abbott plans to borrow money for the deal.

Michael Pearson, Valeant’s Outgoing CEO Admits Dramatic Increases of Certain Drugs was a Mistake

Michael Pearson, Valeant’s Outgoing CEO Admits Dramatic Increases of Certain Dru

On Wednesday, Valeant Pharmaceuticals International Inc's outgoing CEO Mr. Pearson told a Senate committee that the company was too aggressive in radically raising its drug prices and it was a mistake. The company's new CEO and the board members promise that a change will be noticed soon.

Reportedly Pfizer and Allergan Plan to End Merger Deal with New Stricter Tax Rules

Reportedly Pfizer and Allergan Plan to End Merger Deal with New Stricter Tax Rul

In a recent move the U. S Treasury Department proposed stricter rules that will make it difficult for the American companies to shift their tax bases abroad to a lower tax haven.

Investors Get Another Jolt as Valeant Offers Gloomy Earnings Outlook

Investors Get Another Jolt as Valeant Offers Gloomy Earnings Outlook

No matter how Valeant Pharmaceuticals International Inc. tries to win investors favor but its situation gets worse. The company reeling with troubles for months offered a financial outlook on Tuesday which turned out to be worse than people feared. Stocks dropped and the company's market value was cut into almost half.

Tax Fairness Advocates say Pfizer might Avoid Paying $35 Billion in Tax through Merger Deal with Allergan

Tax Fairness Advocates say Pfizer might Avoid Paying $35 Billion in Tax through

On Thursday, a report released by some tax fairness advocates said that Pfizer Inc. by merging with Ireland based Allergan Plc, will be able to avoid paying $35 billion in U. S. taxes permanently. However, a tax and accounting consultant says that the figure portrayed is "a little misleading."

Latest News

Apple’s new ‘macOS Sierra’ version brings Siri to desktop; unfolds several other
SquareTrade conducts dunk/drop tests on iPhone 7, iPhone 7 Plus, Galaxy Note 7
Samsung sued over exploded Galaxy Note 7 handset
Only 13% US Galaxy Note 7 users have exchanged their potentially explosive hands
Uber’s self-driving cars hit Pittsburg roads under a test program
Phil Schiller: Removal of headphone jack marks Apple’s desire for technological
Samsung, CPSC ask Galaxy Note 7 owners to stop using their handsets
Analyst: iPhone 7 will be packaged with EarPods which use Lightning connector
Spacecom may seek $50M or free flight from SpaceX to cover the cost of now-destr
Alphabet is shifting some Nest engineers to Google
Apple sued by iPhone 6 and iPhone 6 Plus owners affected by ‘Touch Disease’ prob
Apple Watch 2 expected to come with some noteworthy new features
Syndicate content